ORMDL3 is a negative regulator of the synthesis of sphingolipids that are produced in response to obesity and related metabolic traits, such as inflammation and insulin resistance21,22, and that interfere with important signaling pathways associated with these traits22. This evidence concerns the gene ORMDL3 and obesity disorder.